Right to FDA-Approved Medicines Act

# Right to FDA-Approved Medicines Act (HR 4525) - Summary **What the Bill Would Do:** This bill aims to protect patients' access to medications that have been approved by the FDA (Food and Drug Administration). While the bill's specific provisions aren't detailed in the available information, the title suggests it would establish or strengthen a legal right for patients to obtain medicines that have already passed FDA safety and effectiveness reviews. This could potentially limit restrictions on which approved drugs doctors can prescribe or patients can access. **Who It Affects:** The bill would primarily affect patients, healthcare providers, and insurance companies. Patients could gain broader access to FDA-approved medications, while insurance companies and healthcare systems might face pressure to cover more treatments.

The pharmaceutical industry could also be impacted depending on the bill's specific requirements. **Current Status:** As of now, HR 4525 is in committee, meaning it has been introduced but hasn't yet advanced to a full vote in the House of Representatives. The bill was sponsored by Representative Deborah K. Ross, a Democrat from North Carolina. *Note: Without access to the bill's detailed text, this summary is based on the title and general framework. For comprehensive details on specific provisions, consult the full bill text on Congress.gov.*.